Correction: The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study.
- DOI
- 10.1186/s12872-026-06036-9
- Published
- 2026 Jun 2
- Container
- BMC cardiovascular disorders
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12872-026-06036-9,
title = {Correction: The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study.},
author = {Yang J and Li X and Tang L and Fan W and Li A and Zhou W and Pang J and Yuan Q and Zhong M and Hou J and Wang L and Liao W and Liu X and Cardiovascular B},
year = {2026},
journal = {BMC cardiovascular disorders},
doi = {10.1186/s12872-026-06036-9},
url = {https://doi.org/10.1186/s12872-026-06036-9}
}RIS
TY - JOUR TI - Correction: The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study. AU - Yang J AU - Li X AU - Tang L AU - Fan W AU - Li A AU - Zhou W AU - Pang J AU - Yuan Q AU - Zhong M AU - Hou J AU - Wang L AU - Liao W AU - Liu X AU - Cardiovascular B PY - 2026 JO - BMC cardiovascular disorders DO - 10.1186/s12872-026-06036-9 UR - https://doi.org/10.1186/s12872-026-06036-9 ER -
APA
J, Y., X, L., L, T., W, F., A, L., W, Z., J, P., Q, Y., M, Z., J, H., L, W., W, L., X, L., & B, C. (2026). Correction: The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study.. BMC cardiovascular disorders. https://doi.org/10.1186/s12872-026-06036-9
Source records
- pubmed · retrieved 2026-09-25T17:51:55.148Z
- europe-pmc · retrieved 2026-09-25T17:51:55.188Z
- doaj · retrieved 2026-09-25T17:51:55.146Z